Niels Junker

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Protein Protein

Locally Advanced

Liver Metastases

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick Schöffski, Rastislav Bahleda, Andrew J Wagner, Melissa A Burgess, Niels Junker, Michael Chisamore, Patrick Peterson, Anna M Szpurka, Matteo Ceccarelli, William D Tap
Results of an Open-label, Phase 1a/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced or Metastatic Soft Tissue Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Charlotte Margareta Brinch, Estrid V S Høgdall, Niels Junker, Holger Jon Moeller, Birgitte Sandfeld-Paulsen, Pieter de Heer, Luit Penninga, Philip Blach Rossen, Anders Krarup-Hansen, Ninna Aggerholm-Pedersen
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor. Cancers 14 (23) (2022)
Charlotte Margareta Brinch, Estrid V S Høgdall, Niels Junker, Holger Jon Moeller, Birgitte Sandfeld-Paulsen, Pieter de Heer, Luit Penninga, Philip Blach Rossen, Anders Krarup-Hansen, Ninna Aggerholm-Pedersen
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor. Cancers 14 (23) (2022)
Charlotte Margareta Brinch, Estrid V S Høgdall, Niels Junker, Holger Jon Moeller, Birgitte Sandfeld-Paulsen, Pieter de Heer, Luit Penninga, Philip Blach Rossen, Anders Krarup-Hansen, Ninna Aggerholm-Pedersen
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor. Cancers 14 (23) (2022)